SAN FRANCISCO, May 29, 2026 (GLOBE NEWSWIRE) -- Omniscient (o8t®), a pioneer in AI-driven brain analysis technology, today announced it has secured $27.2 million (AU$41.1 million) in an oversubscribed Series D funding round. The round is co-led by OIF Ventures and the Australian National Reconstruction Fund Corporation (NRFC), with continued support from long-term investors including Will Vicars and Gina Rinehart AO.

The capital will accelerate commercial expansion of Omniscient's Quicktome® platform and the development of new clinical applications, extending the company's reach into high-growth markets like brain computer interface (BCI), stroke, and movement disorders.

Omniscient's connectomics technology uses AI to decode the wiring of each individual's brain. Their FDA-cleared Quicktome® platform generates patient-specific connectomic maps that visualize functional regions and the neural pathways that are responsible for language, movement, and cognition, giving clinicians insights that ...